Trinity rises up the ranks with bioMerieux coagulation line purchase
This article was originally published in Clinica
Executive Summary
In its biggest acquisition to date, Trinity Biotech has bought the coagulation product line of French diagnostics company bioMerieux for a total sum of up to $51.9m.